CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 71 filers reported holding CULLINAN ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $935,018 | +339.1% | 103,317 | +422.1% | 0.00% | – |
| Q2 2023 | $212,919 | -75.9% | 19,788 | -77.0% | 0.00% | – |
| Q1 2023 | $881,836 | +19.7% | 86,201 | +23.4% | 0.00% | – |
| Q4 2022 | $736,696 | -8.6% | 69,829 | +11.0% | 0.00% | – |
| Q3 2022 | $806,000 | +119.6% | 62,899 | +119.4% | 0.00% | – |
| Q2 2022 | $367,000 | -22.7% | 28,672 | -36.9% | 0.00% | – |
| Q1 2022 | $475,000 | +6.0% | 45,433 | +56.4% | 0.00% | – |
| Q4 2021 | $448,000 | +114.4% | 29,049 | +213.6% | 0.00% | – |
| Q3 2021 | $209,000 | -44.4% | 9,264 | -36.7% | 0.00% | – |
| Q2 2021 | $376,000 | -61.3% | 14,636 | -37.3% | 0.00% | – |
| Q1 2021 | $972,000 | – | 23,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $118,013,000 | 21.52% |
| CHI Advisors LLC | 2,476,720 | $38,215,000 | 12.68% |
| Nextech Invest Ltd. | 1,221,145 | $18,842,000 | 4.96% |
| Foresite Capital Management V, LLC | 1,143,006 | $17,637,000 | 4.33% |
| Foresite Capital Opportunity Management V, LLC | 381,002 | $5,879,000 | 3.94% |
| BVF INC/IL | 5,369,459 | $82,851,000 | 3.01% |
| Boxer Capital, LLC | 1,074,082 | $16,573,000 | 0.64% |
| Logos Global Management LP | 288,458 | $4,450,000 | 0.46% |
| Birchview Capital, LP | 45,114 | $696,000 | 0.45% |
| Eventide Asset Management | 1,440,145 | $21,665,000 | 0.28% |